世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Coronary Heart Disease Diagnostic Imaging Devices Market Outlook 2026-2034: Market Share, and Growth Analysis By Modality (Computed Tomography, Nuclear Medicine, Ultrasound, X rays, Magnetic Resonance Imaging), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers)

Coronary Heart Disease Diagnostic Imaging Devices Market Outlook 2026-2034: Market Share, and Growth Analysis By Modality (Computed Tomography, Nuclear Medicine, Ultrasound, X rays, Magnetic Resonance Imaging), By End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Ambulatory Surgical Centers)


The Coronary Heart Disease Diagnostic Imaging Devices Market is valued at USD 2.19 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach USD 3.52 billion by 2034. Coronary Heart Dise... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
OG Analysis
オージーアナリシス
2025年11月11日 US$3,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
通常3-4営業日以内 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

Summary

The Coronary Heart Disease Diagnostic Imaging Devices Market is valued at USD 2.19 billion in 2025 and is projected to grow at a CAGR of 5.4% to reach USD 3.52 billion by 2034.

Coronary Heart Disease Diagnostic Imaging Devices Market

The coronary heart disease diagnostic imaging devices market consists of imaging systems and associated software used to identify, evaluate and monitor coronary artery disease (CAD) - i.e., atherosclerotic narrowing of coronary arteries - and related ischemic heart conditions. Devices span modalities such as computed tomography (CT) (including coronary CTA), magnetic resonance imaging (MRI), nuclear medicine (PET, SPECT myocardial perfusion), X‑ray/fluoroscopy (coronary angiography imaging), and ultrasound (echocardiography with advanced coronary flow/strain imaging). Key applications include initial diagnosis of suspected CAD, assessment of coronary plaque and stenosis in symptomatic or at‑risk patients, stratification of risk and planning of interventional/cardiac‑surgery treatment, and post‑procedure monitoring (stent/CTO assessment, graft patency). Recent trends include increased use of non‑invasive coronary CTA in lieu of invasive angiography, integration of AI/ML for lesion detection and plaque characterisation, hybrid imaging (PET/CT, PET/MR) for functional plus anatomic assessment, portable/point‑of‑care imaging for remote or resource‑limited settings, and adoption of advanced detector technologies (e.g., photon‑counting CT) for lower radiation dose and higher resolution. Growth drivers include the global rise in CAD prevalence (driven by aging populations, diabetes, obesity and sedentary lifestyles), increasing awareness and screening initiatives for heart disease, expansions in healthcare infrastructure (especially in emerging economies), and the push toward early detection to reduce downstream invasive interventions and cost of care. From a competitive standpoint the market involves large imaging OEMs (CT/MR/nuclear systems) as well as specialist cardiac imaging software providers and service networks; success hinges on modality performance (resolution, speed, radiation/contrast dosage), integration with cardiology workflow and reporting, reimbursement environment (for cardiac imaging), and ability to support remote/digital diagnostics. Additional market considerations: high capital equipment cost and infrastructure requirements can delay adoption in lower‑income settings; operator training and workflow integration remain key; accuracy and clinical validation of new imaging modalities (especially AI‑driven) are becoming differentiators.

Coronary Heart Disease Diagnostic Imaging Devices Market Key Insights

• Non invasive coronary CTA is gaining share As physicians and payers increasingly favour non invasive diagnosis, coronary CT angiography (CTA) is fast emerging as a first line imaging modality for suspected CAD, reducing reliance on invasive angiography for low to moderate risk patients.
• Functional + anatomical imaging synergy Combining anatomical imaging (CT/MR) with functional assessment (PET, SPECT, MRI perfusion) offers more comprehensive CAD evaluation, improving diagnostic accuracy and influencing modality purchasing decisions.
• AI and advanced analytics drive differentiation Software algorithms for plaque quantification, stenosis detection, motion correction, and risk prediction are adding value, enabling faster reading, standardised reporting and potentially improved outcomes, thereby giving vendors competitive edge.
• Emerging markets offer growth frontiers Regions such as Asia Pacific and Latin America are witnessing expansion of cardiac imaging infrastructure, improving affordability of advanced systems, and a large undiagnosed CAD burden - making them high growth territories for diagnostic imaging devices.
• Radiation dose and contrast minimisation matter Patient and clinician concerns over radiation exposure (especially in younger cohorts) and contrast nephropathy are pushing demand for low dose CT, MRI alternatives and improved detector technologies - a factor shaping device selection.
• Workflow and integration with cardiology ecosystem Devices that integrate well into cardiology labs (reporting systems, PACS, catheterisation suites), enable remote or cloud based reporting and support hybrid operating rooms appeal more strongly to hospital systems looking for end to end solutions.
• Reimbursement, regulatory and guideline shifts influence uptake As professional society guidelines evolve (endorsing CTA earlier) and payers recognise value of early CAD detection, reimbursement becomes a major enabler. Conversely, lack of clear reimbursement or regulatory hurdles can slow uptake.
• High end segmentation premium and cost barriers Advanced imaging devices remain high cost capital purchases; hospitals and imaging centres must justify return on investment via case volume, utilisation rates and downstream revenue. This cost barrier can limit penetration in smaller or rural facilities.
• Retrofit and upgrade opportunities exist Many cardiac imaging labs still use older equipment; opportunity exists for retrofit (software upgrades, detector replacements) or modular additions rather than full system replacement, providing quicker ROI for vendors and buyers.
• Service, training and after sales support are differentiators Given complexity of cardiac imaging (motion artefact, contrast protocols, reporting accuracy), device manufacturers and distributors with strong training, support, service network and remote diagnostics capability have a competitive advantage.

Coronary Heart Disease Diagnostic Imaging Devices Market Reginal Analysis

North America

In North America, the market is advanced and relatively mature, driven by high CAD prevalence, significant healthcare spending, and widespread adoption of advanced cardiac imaging modalities. Hospitals and specialised cardiac centres invest in best‑in‑class CT/MR/nuclear systems and AI‑enabled software, supported by reimbursement frameworks and guidelines favouring early detection. Growth is robust but incremental; premium devices dominate, with retrofit/upgrade strategies common.

Europe

Europe’s market is stable, with moderate growth spurred by ageing populations, preventive cardiology initiatives and uptake of non‑invasive imaging. Key factors include stringent regulatory frameworks, multipayer healthcare systems and cost‑containment pressures. Hospitals favour devices that deliver high throughput, lower operating cost and demonstrable clinical value. Emerging countries in Eastern Europe are catching up, offering incremental expansion.

Asia‑Pacific

Asia‑Pacific represents the fastest‑growing market segment, driven by large undiagnosed CAD populations, rapid infrastructure build‑out (new hospitals, imaging centres), rising healthcare expenditure and growing middle‑class health awareness. Many countries deploy CT/MR/nuclear imaging at scale; price sensitivity is higher, so vendors offering cost‑effective, modular or mobile imaging solutions stand to gain. Tele‑cardiology and remote imaging are expanding in rural/suburban markets.

Middle East & Africa

In the Middle East & Africa, opportunities are tied to growing healthcare investment, expansion of private cardiology hospitals and rising CAD incidence. However, uptake is moderated by cost constraints, limited specialist workforce, and variable infrastructure. Stand‑alone imaging centres, mobile imaging units, and partnerships/joint‑ventures with global vendors are common entry strategies.

South & Central America

In South & Central America, the market is evolving. Growth is supported by increasing cardiac disease burden, hospital infrastructure expansion and rising private‑sector investment. However, challenges include lower per‑capita spending, varied reimbursement, and logistical constraints. Vendors that provide flexible financing, leasing models and local service support will be more successful in gaining share

Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation

By Modality
  • Computed Tomography
  • Nuclear Medicine
  • Ultrasound
  • X rays
  • Magnetic Resonance Imaging

    By End-User
  • Hospitals
  • Specialty Clinics
  • Diagnostic Centers
  • Ambulatory Surgical Centers

    Key Market players

    GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, Fujifilm Healthcare, Samsung Medison, Shimadzu, Mindray, Esaote, United Imaging Healthcare, Hologic, Carestream Health, Konica Minolta, Hitachi (Healthcare), Lantheus

    Coronary Heart Disease Diagnostic Imaging Devices Market Analytics

    The report employs rigorous tools, including Porter’s Five Forces, value chain mapping, and scenario-based modelling, to assess supply–demand dynamics. Cross-sector influences from parent, derived, and substitute markets are evaluated to identify risks and opportunities. Trade and pricing analytics provide an up-to-date view of international flows, including leading exporters, importers, and regional price trends. Macroeconomic indicators, policy frameworks such as carbon pricing and energy security strategies, and evolving consumer behaviour are considered in forecasting scenarios. Recent deal flows, partnerships, and technology innovations are incorporated to assess their impact on future market performance.

    Coronary Heart Disease Diagnostic Imaging Devices Market Competitive Intelligence

    The competitive landscape is mapped through OG Analysis’ proprietary frameworks, profiling leading companies with details on business models, product portfolios, financial performance, and strategic initiatives. Key developments such as mergers & acquisitions, technology collaborations, investment inflows, and regional expansions are analyzed for their competitive impact. The report also identifies emerging players and innovative startups contributing to market disruption. Regional insights highlight the most promising investment destinations, regulatory landscapes, and evolving partnerships across energy and industrial corridors.

    Countries Covered

    • North America — Coronary Heart Disease Diagnostic Imaging Devices market data and outlook to 2034
      • United States
      • Canada
      • Mexico
    • Europe — Coronary Heart Disease Diagnostic Imaging Devices market data and outlook to 2034
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • BeNeLux
      • Russia
      • Sweden
    • Asia-Pacific — Coronary Heart Disease Diagnostic Imaging Devices market data and outlook to 2034
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Indonesia
      • Malaysia
      • Vietnam
    • Middle East and Africa — Coronary Heart Disease Diagnostic Imaging Devices market data and outlook to 2034
      • Saudi Arabia
      • South Africa
      • Iran
      • UAE
      • Egypt
    • South and Central America — Coronary Heart Disease Diagnostic Imaging Devices market data and outlook to 2034
      • Brazil
      • Argentina
      • Chile
      • Peru

    * We can include data and analysis of additional countries on demand.

    Research Methodology

    This study combines primary inputs from industry experts across the Coronary Heart Disease Diagnostic Imaging Devices value chain with secondary data from associations, government publications, trade databases, and company disclosures. Proprietary modeling techniques, including data triangulation, statistical correlation, and scenario planning, are applied to deliver reliable market sizing and forecasting.

    Key Questions Addressed

  • What is the current and forecast market size of the Coronary Heart Disease Diagnostic Imaging Devices industry at global, regional, and country levels?
  • Which types, applications, and technologies present the highest growth potential?
  • How are supply chains adapting to geopolitical and economic shocks?
  • What role do policy frameworks, trade flows, and sustainability targets play in shaping demand?
  • Who are the leading players, and how are their strategies evolving in the face of global uncertainty?
  • Which regional “hotspots” and customer segments will outpace the market, and what go-to-market and partnership models best support entry and expansion?
  • Where are the most investable opportunities—across technology roadmaps, sustainability-linked innovation, and M&A—and what is the best segment to invest over the next 3–5 years?

    Your Key Takeaways from the Coronary Heart Disease Diagnostic Imaging Devices Market Report

    • Global Coronary Heart Disease Diagnostic Imaging Devices market size and growth projections (CAGR), 2024-2034
    • Impact of Russia-Ukraine, Israel-Palestine, and Hamas conflicts on Coronary Heart Disease Diagnostic Imaging Devices trade, costs, and supply chains
    • Coronary Heart Disease Diagnostic Imaging Devices market size, share, and outlook across 5 regions and 27 countries, 2023-2034
    • Coronary Heart Disease Diagnostic Imaging Devices market size, CAGR, and market share of key products, applications, and end-user verticals, 2023-2034
    • Short- and long-term Coronary Heart Disease Diagnostic Imaging Devices market trends, drivers, restraints, and opportunities
    • Porter’s Five Forces analysis, technological developments, and Coronary Heart Disease Diagnostic Imaging Devices supply chain analysis
    • Coronary Heart Disease Diagnostic Imaging Devices trade analysis, Coronary Heart Disease Diagnostic Imaging Devices market price analysis, and Coronary Heart Disease Diagnostic Imaging Devices supply/demand dynamics
    • Profiles of 5 leading companies—overview, key strategies, financials, and products
    • Latest Coronary Heart Disease Diagnostic Imaging Devices market news and developments

    Additional Support

    With the purchase of this report, you will receive
    • An updated PDF report and an MS Excel data workbook containing all market tables and figures for easy analysis.
    • 7-day post-sale analyst support for clarifications and in-scope supplementary data, ensuring the deliverable aligns precisely with your requirements.
    • Complimentary report update to incorporate the latest available data and the impact of recent market developments.
    * The updated report will be delivered within 3 working days"

    ページTOPに戻る


    Table of Contents

    1. Table of Contents
    1.1 List of Tables
    1.2 List of Figures

    2. Global Coronary Heart Disease Diagnostic Imaging Devices Market Summary, 2025
    2.1 Coronary Heart Disease Diagnostic Imaging Devices Industry Overview
    2.1.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Revenues (In US$ billion)
    2.2 Coronary Heart Disease Diagnostic Imaging Devices Market Scope
    2.3 Research Methodology

    3. Coronary Heart Disease Diagnostic Imaging Devices Market Insights, 2024-2034
    3.1 Coronary Heart Disease Diagnostic Imaging Devices Market Drivers
    3.2 Coronary Heart Disease Diagnostic Imaging Devices Market Restraints
    3.3 Coronary Heart Disease Diagnostic Imaging Devices Market Opportunities
    3.4 Coronary Heart Disease Diagnostic Imaging Devices Market Challenges
    3.5 Tariff Impact on Global Coronary Heart Disease Diagnostic Imaging Devices Supply Chain Patterns

    4. Coronary Heart Disease Diagnostic Imaging Devices Market Analytics
    4.1 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Key Products, 2025 Vs 2034
    4.2 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Dominant Applications, 2025 Vs 2034
    4.3 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, Leading End Uses, 2025 Vs 2034
    4.4 Coronary Heart Disease Diagnostic Imaging Devices Market Size and Share, High Growth Countries, 2025 Vs 2034
    4.5 Five Forces Analysis for Global Coronary Heart Disease Diagnostic Imaging Devices Market
    4.5.1 Coronary Heart Disease Diagnostic Imaging Devices Industry Attractiveness Index, 2025
    4.5.2 Coronary Heart Disease Diagnostic Imaging Devices Supplier Intelligence
    4.5.3 Coronary Heart Disease Diagnostic Imaging Devices Buyer Intelligence
    4.5.4 Coronary Heart Disease Diagnostic Imaging Devices Competition Intelligence
    4.5.5 Coronary Heart Disease Diagnostic Imaging Devices Product Alternatives and Substitutes Intelligence
    4.5.6 Coronary Heart Disease Diagnostic Imaging Devices Market Entry Intelligence

    5. Global Coronary Heart Disease Diagnostic Imaging Devices Market Statistics – Industry Revenue, Market Share, Growth Trends and Forecast by segments, to 2034
    5.1 World Coronary Heart Disease Diagnostic Imaging Devices Market Size, Potential and Growth Outlook, 2024- 2034 ($ billion)
    5.1 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By Modality, 2024- 2034 ($ billion)
    5.2 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By End-User, 2024- 2034 ($ billion)
    5.3 Global Coronary Heart Disease Diagnostic Imaging Devices Sales Outlook and CAGR Growth By Segmentation3, 2024- 2034 ($ billion)
    5.4 Global Coronary Heart Disease Diagnostic Imaging Devices Market Sales Outlook and Growth by Region, 2024- 2034 ($ billion)

    6. Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Industry Statistics – Market Size, Share, Competition and Outlook
    6.1 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Insights, 2025
    6.2 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By Modality, 2024- 2034 (USD billion)
    6.3 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By End-User, 2024- 2034 (USD billion)
    6.4 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast By Segmentation3, 2024- 2034 (USD billion)
    6.5 Asia Pacific Coronary Heart Disease Diagnostic Imaging Devices Market Revenue Forecast by Country, 2024- 2034 (USD billion)
    6.5.1 China Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
    6.5.2 India Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
    6.5.3 Japan Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034
    6.5.4 Australia Coronary Heart Disease Diagnostic Imaging Devices Market Size, Opportunities, Growth 2024- 2034

    7. Europe Coronary Heart Disease Diagnostic Imaging Devices Market Data, Penetration, and Business Prospects to 2034
    7.1 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Key Findings, 2025
    7.2 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By Modality, 2024- 2034 (USD billion)
    7.3 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By End-User, 2024- 2034 (USD billion)
    7.4 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown By Segmentation3, 2024- 2034 (USD billion)
    7.5 Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size and Percentage Breakdown by Country, 2024- 2034 (USD billion)
    7.5.1 Germany Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
    7.5.2 United Kingdom Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
    7.5.2 France Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
    7.5.2 Italy Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034
    7.5.2 Spain Coronary Heart Disease Diagnostic Imaging Devices Market Size, Trends, Growth Outlook to 2034

    8. North America Coronary Heart Disease Diagnostic Imaging Devices Market Size, Growth Trends, and Future Prospects to 2034
    8.1 North America Snapshot, 2025
    8.2 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By Modality, 2024- 2034 ($ billion)
    8.3 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By End-User, 2024- 2034 ($ billion)
    8.4 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook By Segmentation3, 2024- 2034 ($ billion)
    8.5 North America Coronary Heart Disease Diagnostic Imaging Devices Market Analysis and Outlook by Country, 2024- 2034 ($ billion)
    8.5.1 United States Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Canada Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034
    8.5.1 Mexico Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share, Growth Trends and Forecast, 2024- 2034

    9. South and Central America Coronary Heart Disease Diagnostic Imaging Devices Market Drivers, Challenges, and Future Prospects
    9.1 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Data, 2025
    9.2 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By Modality, 2024- 2034 ($ billion)
    9.3 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By End-User, 2024- 2034 ($ billion)
    9.4 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future By Segmentation3, 2024- 2034 ($ billion)
    9.5 Latin America Coronary Heart Disease Diagnostic Imaging Devices Market Future by Country, 2024- 2034 ($ billion)
    9.5.1 Brazil Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share and Opportunities to 2034
    9.5.2 Argentina Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share and Opportunities to 2034

    10. Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Outlook and Growth Prospects
    10.1 Middle East Africa Overview, 2025
    10.2 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By Modality, 2024- 2034 (USD billion)
    10.3 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By End-User, 2024- 2034 (USD billion)
    10.4 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics By Segmentation3, 2024- 2034 (USD billion)
    10.5 Middle East Africa Coronary Heart Disease Diagnostic Imaging Devices Market Statistics by Country, 2024- 2034 (USD billion)
    10.5.1 Middle East Coronary Heart Disease Diagnostic Imaging Devices Market Value, Trends, Growth Forecasts to 2034
    10.5.2 Africa Coronary Heart Disease Diagnostic Imaging Devices Market Value, Trends, Growth Forecasts to 2034

    11. Coronary Heart Disease Diagnostic Imaging Devices Market Structure and Competitive Landscape
    11.1 Key Companies in Coronary Heart Disease Diagnostic Imaging Devices Industry
    11.2 Coronary Heart Disease Diagnostic Imaging Devices Business Overview
    11.3 Coronary Heart Disease Diagnostic Imaging Devices Product Portfolio Analysis
    11.4 Financial Analysis
    11.5 SWOT Analysis

    12 Appendix
    12.1 Global Coronary Heart Disease Diagnostic Imaging Devices Market Volume (Tons)
    12.1 Global Coronary Heart Disease Diagnostic Imaging Devices Trade and Price Analysis
    12.2 Coronary Heart Disease Diagnostic Imaging Devices Parent Market and Other Relevant Analysis
    12.3 Publisher Expertise
    12.2 Coronary Heart Disease Diagnostic Imaging Devices Industry Report Sources and Methodology

  •  

    ページTOPに戻る

    ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

    webからのご注文・お問合せはこちらのフォームから承ります

    本レポートと同分野(自動車市場)の最新刊レポート

    OG Analysis社の 自動車・輸送分野 での最新刊レポート

    本レポートと同じKEY WORD(coronary)の最新刊レポート

    • 本レポートと同じKEY WORDの最新刊レポートはありません。

    よくあるご質問


    OG Analysis社はどのような調査会社ですか?


    OG Analysisは、10年以上の専門知識を持ち、半導体、エネルギー、化学品、自動車、農業など多様な市場調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行っています。 もっと見る


    調査レポートの納品までの日数はどの程度ですか?


    在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
    但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
    発注をする前のお問合せをお願いします。


    注文の手続きはどのようになっていますか?


    1)お客様からの御問い合わせをいただきます。
    2)見積書やサンプルの提示をいたします。
    3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
    4)データリソース社からレポート発行元の調査会社へ納品手配します。
    5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


    お支払方法の方法はどのようになっていますか?


    納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
    お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
    請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
    お客様の御支払い条件が60日以上の場合は御相談ください。
    尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


    データリソース社はどのような会社ですか?


    当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
    世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
    お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。


    詳細検索

    このレポートへのお問合せ

    03-3582-2531

    電話お問合せもお気軽に

     

     

    2025/12/02 10:26

    156.70 円

    182.16 円

    209.66 円

    ページTOPに戻る